• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Archives

    Monthly Archive for: "September, 2020"
    Home / 2020 / September
      0
    By Marit Holleman
    In Uncategorized Posted September 25, 2020

    Vacancies at Working Group on New TB Vaccines

    The Working Group on New TB Vaccines (WGNV) has several vacancies: WGNV Core Group Position Description – Early Career Researcher WGNV Core Group Position Description – Affected [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted September 24, 2020

    The Working Group on New TB Vaccines launches an updated website

    The Stop TB Partnership Working Group on New TB Vaccines (WGNV) has launched an updated website. WGNV helps to facilitate the development of new, more effective TB vaccines by promoting [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted September 1, 2020

    The European Investment Bank agreed €30 million loan to accelerate TB vaccine development

    The European Investment Bank (EIB) agreed a €30 million loan with Vakzine Projekt Management GmbH (VPM). This loan will help VPM to perform the priMe trial. The priMe project contains a [...]

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No